Cannabis
Nass Valley Gateway Ltd (NVG) Announces CEO Transition
Michael Semler, Former CFO, Will Succeed Gavin Collier as Internal Succession Plan Is Revealed
Vancouver, British Columbia–(Newsfile Corp. – April 12, 2021) – Nass Valley Gateway Ltd. (CSE: NVG); (OTC Pink: NSVGF) (FSE: 3NVN), distributor of top quality, broad and full spectrum CBD products, is pleased to announce Michael Semler, former CFO and director of Nass Valley Gateway Ltd., has been named by the board of directors as the company’s next CEO, effective immediately. Gavin Collier, who served for the last two years as CEO, decided to step down to pursue other professional opportunities. He will stay with the company as a close advisor.
Gavin Collier stated, “Michael Semler is the natural choice to be NVG’s next CEO. His strategic vision has been integral in launching Nass Valley and his passion, integrity and health and wellness industry experience are ideal characteristics to lead Nass Valley’s team to the next level.”
ABOUT NASS VALLEY GATEWAY LTD:
Nass Valley Gateway LTD (NVG) is a publicly traded company listed on the CSE, focused on the sales and distribution of organic, non-GMO, CBD products for pet and human consumption. Nass Valley CBD products are sold under the “Nass Valley Gardens” brand, an affiliate, via retail, wholesale, direct sales, and digital sales channels.
We seek Safe Harbor.
Neither the CSE nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of the contents of this news release.
Company: Nass Valley Gateway Ltd.
422 Richards Street, Suite 170
V6B 2Z4 Vancouver
Canada
E-mail: [email protected]
Corporate Website: www.nassvalleygateway.com
Product Website: www.nassvalleyproducts.com
Investor Relations
Michael Semler.
+1 (609) 651-0032
[email protected]
Listed: Regulated Unofficial Market in Berlin, Frankfurt, Hamburg,
Stuttgart; Toronto
EQS News ID: 818503
Source: Nass Valley Gateway Ltd
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/80207
Cannabis
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
Cannabis
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
Cannabis
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis2 weeks ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 weeks ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
SCHWAZZE2 weeks ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis2 weeks ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
-
Cannabis6 days ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis5 days ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Innocan4 days ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey